This study was designed to investigate the combined effects of cadmium (Cd) and lead (Pb) on 10-year coronary heart disease (CHD) risk calculated using the Framingham risk score. The heavy metal data set of the Korean National Health and Nutrition Examination Survey IV and V (2008-2010) was analyzed. The 10-year CHD risk was significantly associated with the log-transformed blood Cd and Pb levels in Korean men. For the highest quartile of Cd and Pb, the odds ratio (OR) of the intermediate risk and beyond for CHD (10-year risk ≥10%) compared to the lowest quartile was 6.870 (Cd, 95% confidence interval [CI]: 4.58-10.30) and 3.127 (Pb, 95% CI: 2.09-4.69) after adjusting for confounders, respectively. The adjusted OR of the intermediate risk and beyond for CHD (10-year risk ≥10%) in the fourth quartile of both Cd and Pb was 12.2 (95% CI: 8.0-18.5) compared to the reference group (first and second quartiles of Cd and Pb). However, the association between log-transformed blood Cd and Pb and the 10-year CHD risk was not significant in Korean women.
TalbertRL. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III. Am J Manag Care. 2002;8(12 suppl):S301–S307.
2.
D’AgostinoRBSrVasanRSPencinaMJ. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753.
3.
GallagherCMMelikerJR. Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis. Environ Health Perspect. 2010;118(12):1676–1684.
AgarwalSZamanTTuzcuEMKapadiaSR. Heavy metals and cardiovascular disease: results from the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Angiology. 2011;62(5):422–429.
6.
SponderMFritzer-SzekeresMMarculescuR. Blood and urine levels of heavy metal pollutants in female and male patients with coronary artery disease. Vasc Health Risk Manag. 2014;10:311–317.
7.
MyongJPKimHRJangTWLeeHEKooJW. Association between Blood Cadmium Levels and 10-Year Coronary Heart Disease Risk in the General Korean Population: The Korean National Health and Nutrition Examination Survey 2008-2010. PLoS ONE. 2014;9(11):e111909.
8.
NashDMagderLLustbergM. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. J Am Med Assoc. 2003;289(12):1523–1532.
9.
SchoberSMirelLBGraubardBIBrodyDJFlegalKM. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III Mortality Study. Environ Health Perspect. 2006;114(10):1538–1541.
10.
AdemuyiwaOAgarwalRChandraRBehariJR. Lead-induced phospholipidosis and cholesterogenesis in rat tissues. Chem Biol Interact. 2009;179(2-3):314–320.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final report. Circulation. 2002;106(25):3143–3421.
13.
SarkarSYadavPTrivediRBansalAKBhatnagarD. Cadmium-induced lipid peroxidation and the status of the antioxidant system in rat tissues. JTrace Elem Med Biol. 1995;9(3):144–149.
14.
SatarugSNishijoMLaskerJMEdwardsRJMooreMR. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases?Tohoku J Exper Med. 2006;208(3):179–202.
15.
HoutmanJP. Prolonged low-level cadmium intake and atherosclerosis. Sci Total Environ. 1993;138(1-3):31–36.
16.
EverettCJFrithsenIL. Association of urinary cadmium and myocardial infarction. Environ Res. 2008;106(2):284–286.
17.
PontevaMElomaaIBäckmanHHanssonLKilpiöJ. Blood cadmium and plasma zinc measurements in acute myocardial infarction. Eur J Cardiol. 1979;9(5):379–391.
18.
Adamska-DyniewskaHBała aTFlorczakHTrojanowskaB. Blood cadmium in healthy subjects and in patients with cardiovascular diseases. Cor Vasa. 1982;24(6):441–447.
19.
MessnerBKnoflachMSeubertA. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol. 2009;29(9):1392–1398.
20.
Tellez-PlazaMNavas-AcienACrainiceanuCMGuallarE. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect. 2008;116(1):51–56.
21.
VaroniMVPalombaDGianorsoSAnaniaV. Cadmium as an environmental factor of hypertension in animals: new perspectives on mechanisms. Vet Res Comm. 2003;27(1):807–810.
22.
ValkoMMorrisHCroninMT. Metals, toxicity and oxidative stress. Curr Medicinal Chem. 2005;12(10):1161–1208.
23.
SatarugSNishijoMUjjinPVanavanitkunYMooreMR. Cadmium induced nephropathy in the development of high blood pressure. Toxicol Lett. 2005;157(1):57–68.
24.
AlghashamAAMekiARIsmailHA. Association of blood lead level with elevated blood pressure in hypertensive patients. Int J Health Sci (Qassim). 2011;5(1):17–27.
25.
VahterMAkessonALidénC. Gender differences in the disposition and toxicity of metals. Environ Res. 2007;104(1):85–95.
26.
NordbergGFNogawaKNordbergM. Cadmium. In: NordbergGFFowlerBFNordbergM, eds. Handbook on the Toxicology of Metals. Amsterdam, The Netherlands: Elsevier; 2007:445–486.
27.
KwonCSKountouriAMMayerC. Mononuclear cell metallothionein mRNA levels in human subjects with poor zinc nutrition. Br J Nutr. 2007;97(2):247–254.
28.
SogawaNSogawaCAOdaN. The effects of ovariectomy and women sex hormones on hepatic metallothionein-I gene expression after injection of cadmium chloride in mice. Pharmacol Res. 2001;44(1):53–57.
